BDBM181150 US9138431, R-NORKETOTIFEN (RNORK)::US9138431, RS-NORKETOTIFEN (NORK)::US9138431, RS-NORKETOTIFEN (RSNORK)::US9138431, S-NORKETOTIFEN (SNORK)::US9333199, RS-NORKETOTIFEN (NORK)

SMILES O=[#6]-1-[#6]-c2ccccc2\[#6](-c2ccsc-12)=[#6]-1/[#6]-[#6]-[#7]-[#6]-[#6]-1

InChI Key InChIKey=GKMBBMIOTOVNQA-UHFFFAOYSA-N

Data  1 KI  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 181150   

TargetHistamine H4 receptor(Human)
Bridge Pharma

US Patent
LigandPNGBDBM181150(US9333199, RS-NORKETOTIFEN (NORK) | US9138431, RS-...)
Affinity DataIC50: 2.00E+3nMAssay Description:Histamine H-4 Receptor Binding AssayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/6/2016
Entry Details
Go to US Patent

TargetHistamine H1 receptor(Human)
Bridge Pharma

US Patent
LigandPNGBDBM181150(US9333199, RS-NORKETOTIFEN (NORK) | US9138431, RS-...)
Affinity DataIC50: 1.10E+4nMAssay Description:Affinities of the test compounds for peripheral human histamine H-1-receptors were assessed using receptor-binding assays. The specific binding of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/6/2016
Entry Details
Go to US Patent

TargetHistamine H1 receptor(Human)
Bridge Pharma

US Patent
LigandPNGBDBM181150(US9333199, RS-NORKETOTIFEN (NORK) | US9138431, RS-...)
Affinity DataIC50: 1.10E+4nMAssay Description:The specific binding of the radioactive ligand to the receptor was defined as the difference between total binding and nonspecific binding, determine...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent

TargetHistamine H4 receptor(Human)
Bridge Pharma

US Patent
LigandPNGBDBM181150(US9333199, RS-NORKETOTIFEN (NORK) | US9138431, RS-...)
Affinity DataKi:  2.00E+3nMAssay Description:The specific binding of the radioactive ligand to the receptor was defined as the difference between total binding and nonspecific binding, determine...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/15/2017
Entry Details
Go to US Patent